Fogarasi, A., & Witt, O. (2016). EFFECTS: An expanded access program of everolimus for patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complex. BMC neurology, 16, . https://doi.org/10.1186/s12883-016-0658-4
Chicago Style (17th ed.) CitationFogarasi, Andras, and Olaf Witt. "EFFECTS: An Expanded Access Program of Everolimus for Patients with Subependymal Giant Cell Astrocytoma Associated with Tuberous Sclerosis Complex." BMC Neurology 16 (2016). https://doi.org/10.1186/s12883-016-0658-4.
MLA (9th ed.) CitationFogarasi, Andras, and Olaf Witt. "EFFECTS: An Expanded Access Program of Everolimus for Patients with Subependymal Giant Cell Astrocytoma Associated with Tuberous Sclerosis Complex." BMC Neurology, vol. 16, 2016, https://doi.org/10.1186/s12883-016-0658-4.